These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32650468)

  • 41. Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
    Do DV; Ong CT; Khoo YT; Carbone A; Lim CP; Wang S; Mukhopadhyay A; Cao X; Cho DH; Wei XQ; Bellone G; Lim I; Phan TT
    Br J Dermatol; 2012 Jun; 166(6):1275-88. PubMed ID: 22050194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.
    Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT
    J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling.
    Liu J; Ren J; Su L; Cheng S; Zhou J; Ye X; Dong Y; Sun S; Qi F; Liu Z; Pleat J; Zhai H; Zhu N
    Burns; 2018 Mar; 44(2):370-385. PubMed ID: 29029852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p53 and apoptosis alterations in keloids and keloid fibroblasts.
    Ladin DA; Hou Z; Patel D; McPhail M; Olson JC; Saed GM; Fivenson DP
    Wound Repair Regen; 1998; 6(1):28-37. PubMed ID: 9776848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures.
    Abergel RP; Pizzurro D; Meeker CA; Lask G; Matsuoka LY; Minor RR; Chu ML; Uitto J
    J Invest Dermatol; 1985 May; 84(5):384-90. PubMed ID: 3998489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.
    Tuan TL; Hwu P; Ho W; Yiu P; Chang R; Wysocki A; Benya PD
    Am J Pathol; 2008 Nov; 173(5):1311-25. PubMed ID: 18832570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concentration-dependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing.
    Xian LJ; Chowdhury SR; Bin Saim A; Idrus RB
    Cytotherapy; 2015 Mar; 17(3):293-300. PubMed ID: 25456581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
    Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
    J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insufficient expression of the melanocortin-1 receptor by human dermal fibroblasts contributes to excess collagen synthesis in keloid scars.
    Luo LF; Shi Y; Zhou Q; Xu SZ; Lei TC
    Exp Dermatol; 2013 Nov; 22(11):764-6. PubMed ID: 24433185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts.
    Hasegawa T; Nakao A; Sumiyoshi K; Tsuboi R; Ogawa H
    J Dermatol Sci; 2003 Jun; 32(1):19-24. PubMed ID: 12788525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normal and keloid fibroblasts are differentially influenced by IFN-γ and triamcinolone as well as by their combination.
    Euler T; Valesky EM; Meissner M; Hrgovic I; Kaufmann R; Kippenberger S; Zöller NN
    Wound Repair Regen; 2019 Sep; 27(5):450-461. PubMed ID: 30994217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of sialic acid on the gene expression of fibrillar collagens: different changes in normal and fibrotic scar derived fibroblasts.
    Kössi J; Aalto J; Haataja S; Niinikoski J; Peltonen J; Laato M
    Ann Chir Gynaecol Suppl; 2001; (215):25-8. PubMed ID: 12016744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways.
    Zhang Q; Kelly AP; Wang L; French SW; Tang X; Duong HS; Messadi DV; Le AD
    J Invest Dermatol; 2006 Dec; 126(12):2607-13. PubMed ID: 16841034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting of Sp1 transcription factor: a novel therapeutic approach for keloids, an in vitro analysis.
    Mukhopadhyay A; Khoo A; Cheong HH; Chan SY; Aalami O; Lim IJ; Phan TT
    Exp Dermatol; 2007 Dec; 16(12):1023-31. PubMed ID: 18031462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of genistein on c-Jun, c-Fos and Fos-B of AP-1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts cultured in vitro.
    Jurzak M; Adamczyk K
    Acta Pol Pharm; 2013; 70(2):205-13. PubMed ID: 23614275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of collagen synthesis by IWR-1 in normal and keloid-derived skin fibroblasts.
    Zhou MW; Yin WT; Jiang RH; Lee JH; Kim CD; Lee JH; Zhu MJ; Yoon TJ
    Life Sci; 2017 Mar; 173():86-93. PubMed ID: 27939785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of keratinocyte regulation of collagen I synthesis by dermal fibroblasts in a simple in vitro model.
    Harrison CA; Gossiel F; Bullock AJ; Sun T; Blumsohn A; Mac Neil S
    Br J Dermatol; 2006 Mar; 154(3):401-10. PubMed ID: 16445767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
    Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
    Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.